United States · Who invested in KSQ Therapeutics?
KSQ Therapeutics's investors include Alexandria Real Estate Equities, Polaris Partners, ARCH Venture Partners, Invus and Lilly Asia Ventures, and 5 more on record.
2018
$76MRound$80MSeries C
United States · Series C startup
Who invested in KSQ Therapeutics
Funding summaryUpdated 26 Oct 2026
$156Mraised across 2 rounds since 2017, from 2 sources
$76MRound$80MSeries C
- Latest round
- Series C, $80MSept 2018
- Investors
- 10
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $76M Oct 2017
- Biggest round
- $80M Series C · Sept 2018
- Between rounds
- 12 months from the last two
The rounds
- Sept 2018Series C$80M7 new1 returning
Polaris Partners
ARCH Venture Partners
Invus- Lilly Asia Ventures
Alexandria Real Estate Equities- Baillie Gifford
Flagship Pioneering
Cowen Group
Reported by FinSMEsSEC filing: $81M sold, first sale Sept 2018
- Oct 2017
Founders and team
From KSQ Therapeutics's own website: 11 on the team.
- Qasim RizviChief Executive Officer
- Anna Truppel-HartmannChief Medical Officer
- Chris HeberligChief Financial Officer
- Lance OstromChief Business Officer
- Micah BensonChief Scientific Officer
- Thomas LeitchChief Technology Officer
- Elizabeth Twomey-GanslerHead of Human Resources
- Patty HarrisHead of Clinical Development
- David DarstBoard Member
- Doug ColeChairman of the Board
- Mahesh KarandeBoard Member
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Round2017Series C2018Alexandria Real Estate EquitiesPolaris PartnersARCH Venture PartnersInvusLilly Asia VenturesBaillie GiffordFlagship Pioneering
ArchCowen GroupFlagship Pioneering/ Polaris
Alexandria Real Estate EquitiesPolaris PartnersARCH Venture PartnersInvusLilly Asia VenturesBaillie GiffordFlagship PioneeringArchCowen GroupFlagship Pioneering/ PolarisEveryone who backed them
Lilly Asia VenturesVC firm1round
Baillie GiffordAsset manager1round
Flagship Pioneering/ Polarisno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about KSQ Therapeutics
How much has KSQ Therapeutics raised?
KSQ Therapeutics has raised $156M across 2 rounds since 2017.
When did KSQ Therapeutics last raise?
KSQ Therapeutics's most recent round was a Series C of $80M in Sept 2018.
What was KSQ Therapeutics's biggest round?
Its most recent round, $80M in Sept 2018, is also its largest on record.
Who backed KSQ Therapeutics first?
KSQ Therapeutics's first round on record, in Oct 2017, was backed by Alexandria Real Estate Equities, Arch and Flagship Pioneering/ Polaris.
What stage is KSQ Therapeutics at?
KSQ Therapeutics's latest named round is a Series C, in Sept 2018.
Where is KSQ Therapeutics based?
KSQ Therapeutics is based in the United States.
Companies like KSQ Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.